Concepedia

Esilida Sula Karreci

ES

Statistics

Publications

3

Citations

220

H-Index

3

Active since

2016

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

Esilida Sula Karreci is an author at Brigham and Women's Hospital specializing in immunology, cell biology, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2018

3

Publications

3

Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression

Yawara Kawano, Oksana Zavidij, Jihye Park et al. · Journal of Clinical Investigation · 2018 · 106 citations · Full text

, , +16

Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice

Esilida Sula Karreci, Hao Fan, Mayuko Uehara et al. · Proceedings of the National Academy of Sciences · 2016 · 68 citations · Full text

Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation

Esilida Sula Karreci, Siawosh K. Eskandari, Farokh Dotiwala et al. · JCI Insight · 2017 · 46 citations · Full text

, , +21

Rows per page

1–3 of 3